ReviewMedical2026

Associations Between Cannabis Use and Sleep Outcomes in a Sample of Pregnant Women.

Gorelik A.; Kinstler E.; Cuñado A.; Cox R.; Constantino-Pettit A.; Leverett S.; Hatoum A.; Lenze S.; Smyser C.; Rogers C. et al. · medRxiv : the preprint server for health sciences · 2026

Research summary

**Background & Methods** This prospective cohort study enrolled 441 pregnant women with lifetime cannabis use history (298 users, 143 non-users during pregnancy) and assessed associations between cannabis use across trimesters and sleep outcomes. Cannabis use was measured via self-report and urine drug screening at each trimester, while sleep was evaluated using validated scales (Women's Health Initiative Insomnia Rating Scale, Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index) at each trimester, with cotinine measured as a covariate for nicotine exposure. **Key Findings** • Cannabis use during pregnancy showed a trimester-dependent association with insomnia, with third trimester use associated with significantly elevated insomnia symptoms (F(2,737.81)=4.98, P FDR =0.03) compared to non-use, but no significant associations with daytime sleepiness, subjective sleep quality overall, or restless legs symptoms. • Women who reported sleep difficulties as their primary motivation for cannabis use during pregnancy experienced worse insomnia symptoms (F(1, 223)=13.09, P FDR =0.001) and poorer sleep quality (F(1, 219)=7.86, P FDR =0.01) across pregnancy compared to those using cannabis for other reasons. • The findings suggest a paradoxical effect: despite common perception that cannabis improves sleep, women using it specifically to manage sleep problems demonstrated greater sleep impairment than those with other motivations for use. **Dosage & Administration** Not reported. **Safety & Adverse Effects** Not reported beyond sleep outcomes. The study excluded women with heavy episodic alcohol consumption or use of other illicit substances. **Evidence Quality** This preprint study has notable limitations: reliance on self-reported cannabis use with only partial corroboration via urine drug screening; relatively small sample size; inability to determine causality or directionality (whether sleep problems precede, follow, or are caused by cannabis use); lack of dose quantification; and cross-sectional confounding unmeasured. The study represents moderate evidence in a pregnant population, a vulnerable group where causality determination is ethically challenging. The authors acknowledge uncertainty about whether sleep difficulties represent a true cannabis effect, a pre-existing condition, or an epiphenomenon requiring future investigation.

Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.

Journal
medRxiv : the preprint server for health sciences
Year
2026
Study type
Review
Read the original paper (DOI) ↗
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed

More recent cannabis research

This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.

← Back to home